Drug firm Ipca Laboratories today posted 58.28% rise in its net profit at Rs 139.12 crore for the third quarter ended December 31, 2013.
The company had posted a net profit of Rs 87.89 crore in the same period previous fiscal.
Net sales of the company rose to Rs 815.15 crore during the third quarter this fiscal compared to Rs 692.41 crore in the same period previous fiscal, Ipca Laboratories said in a filing to the BSE.
Shares of Ipca Laboratories were trading at Rs 778 apiece on the BSE in late afternoon trade, up 1.25% from their previous close.